Ionis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for olezarsen for severe ...
Mississippi voters will soon head to the polls to cast their ballots for U.S. Senate and House candidates in March’s primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results